Jacques Zimmer

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Infectious Diseases

Natural Killer Cells

Top Venues

Cellular & molecular immunology

The Medical journal of Australia

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jacques Zimmer, Camille Rolin, Markus Ollert
Two hits are better than one: rational dual strategy efficiently fights neuroblastoma. Signal transduction and targeted therapy 9 (1) (2024)
Jacques Zimmer, Markus Ollert
Good's syndrome associated with multiple basal cell carcinomas. The Medical journal of Australia 220 (8) (2024)
Jacques Zimmer, Markus Ollert
Good's syndrome associated with multiple basal cell carcinomas. The Medical journal of Australia (2024)
Camille Rolin, Jacques Zimmer, Carole Seguin-Devaux
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases. Cellular & molecular immunology (2024)
Camille Rolin, Jacques Zimmer, Carole Seguin-Devaux
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases. Cellular & molecular immunology 21 (7) (2024)
Jacques Zimmer, Markus Ollert
Good's syndrome associated with multiple basal cell carcinomas. The Medical journal of Australia 220 (8) (2024)
Jacques Zimmer, Camille Rolin, Markus Ollert
Two hits are better than one: rational dual strategy efficiently fights neuroblastoma. Signal transduction and targeted therapy 9 (1) (2024)
Camille Rolin, Jacques Zimmer, Carole Seguin-Devaux
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases. Cellular & molecular immunology 21 (7) (2024)
Jacques Zimmer, Markus Ollert
Good's syndrome associated with multiple basal cell carcinomas. The Medical journal of Australia 220 (8) (2024)
Camille Rolin, Jacques Zimmer, Carole Seguin-Devaux
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases. Cellular & molecular immunology 21 (7) (2024)
Jacques Zimmer, Camille Rolin, Markus Ollert
Two hits are better than one: rational dual strategy efficiently fights neuroblastoma. Signal transduction and targeted therapy 9 (1) (2024)
Camille Rolin, Jacques Zimmer, Carole Seguin-Devaux
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases. Cellular & molecular immunology 21 (7) (2024)
Jacques Zimmer, Camille Rolin, Markus Ollert
Two hits are better than one: rational dual strategy efficiently fights neuroblastoma. Signal transduction and targeted therapy 9 (1) (2024)
Jacques Zimmer, Vladimir Jurišić
Special Issue "New Developments in Natural Killer Cells for Immunotherapy". Cells 12 (11) (2023)
Aurélie Poli, Anaïs Oudin, Arnaud Muller, Ilaria Salvato, Andrea Scafidi, Oliver Hunewald, Olivia Domingues, Petr V Nazarov, Vincent Puard, Virginie Baus, Francisco Azuaje, Gunnar Dittmar, Jacques Zimmer, Tatiana Michel, Alessandro Michelucci, Simone P Niclou, Markus Ollert
Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice. Allergy (2022)
Tatiana Michel, Markus Ollert, Jacques Zimmer
A Hot Topic: Cancer Immunotherapy and Natural Killer Cells. International journal of molecular sciences 23 (2) (2022)
Neha D Patil, Jonathan D Turner, Mahesh S Desai, Jacques Zimmer
Trained through generations. Cellular & molecular immunology 19 (6) (2022)
Neha D Patil, Maud Theresine, Jacques Zimmer
Human natural killer cells in major histocompatibility complex class I deficiency. Scandinavian journal of immunology 94 (2) (2021)
Jacques Zimmer
Danazol as a second-line treatment for immune thrombocytopenic purpura. European journal of haematology 102 (1) (2018)